Status:
COMPLETED
dTMS in Obsessive Compulsive Disorder
Lead Sponsor:
Pamukkale University
Conditions:
Obsessive-Compulsive Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
High-frequency deep transcranial magnetic stimulation (dTMS) over the medial prefrontal cortex (mPFC) and the anterior cingulate cortex (ACC) with an H-coil has been approved by the Food and Drug Admi...
Detailed Description
The current study aimed to investigate the efficacy and safety of multiple deep stimulations per day with a double-cone coil to the mPFC and ACC in treatment-resistant patients with OCD. This study ev...
Eligibility Criteria
Inclusion
- Clinical diagnosis of obsessive-compulsive disorder
- Not having an adequate response to treatment despite using at least two selective serotonin reuptake inhibitors at a sufficient dose and duration for 12 weeks before the planned add-on treatment
- Aged 18-65 years
- Able to read and write
Exclusion
- Not providing consent to participate in the study
- Diagnosis of a psychiatric disorder, such as psychotic disorder, bipolar disorder, major depressive disorder \[Hamilton Depression Rating Scale (HDRS) score above 17\], mental retardation, alcohol-substance use disorder, and organic mental disorder (dementia, delirium, and head trauma, etc.)
- Diagnosis of an important medical or neurological disease (e.g., epilepsy);
- Mental retardation
- Illiteracy
- Having received electroconvulsive therapy (ECT) or TMS within the last six months;
- Having any prosthesis, such as an implant and pacemaker.
Key Trial Info
Start Date :
November 27 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 25 2023
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06077370
Start Date
November 27 2022
End Date
May 25 2023
Last Update
October 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pamukkale University
Denizli, Turkey (Türkiye), 20160